Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1028-1033.DOI: 10.12114/j.issn.1007-9572.2023.0422
Special Issue: 儿科最新文章合集
• Frontiers of Medicine • Previous Articles Next Articles
Received:
2023-07-17
Revised:
2023-09-13
Published:
2024-03-20
Online:
2023-12-19
Contact:
LIN Zheng
通讯作者:
林征
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0422
评估工具 | 时间(年) | 测评形式 | 适用人群 | Cronbach's α系数 | 汉化版 | 优点 | 缺点 |
---|---|---|---|---|---|---|---|
青少年饮食紊乱调查问卷(EDY-Q)[ | 2013 | 自陈量表 | ≥14岁 | 0.62 | 无 | ①简单快捷 ②可以区分其他进食障碍 | ①信度较低 |
九项回避性/限制性摄食障碍筛查量表(NIAS)[ | 2017 | 自陈量表 | ≥12岁 | 多样本检验为0.79~0.90 | 有 | ①简单快捷 ②信效度较好 | ①需结合其他量表进行区分 ②不适合胃肠道疾病患者筛查 |
回避性/限制性摄食障碍父母报告版问卷(ARFID-Q-PR)[ | 2022 | 他评量表 | 2~10岁儿童 | 0.84 | 无 | ①可以区分其他进食障碍 ②信效度较好 | ①有待在多样本人群推广验证 |
异食癖、回避性/限制性摄食障碍和反刍障碍访谈(PARDI)[ | 2019 | 半结构化访谈 | 全年龄段使用 | 评估ARFID分量表各维度为0.83~0.93 | 无 | ①可用于诊断 ②信效度较好 | ①需要心理医生指导使用 ②大规模筛查人力成本较高 |
Table 1 Characteristics of ARFID assessment tools
评估工具 | 时间(年) | 测评形式 | 适用人群 | Cronbach's α系数 | 汉化版 | 优点 | 缺点 |
---|---|---|---|---|---|---|---|
青少年饮食紊乱调查问卷(EDY-Q)[ | 2013 | 自陈量表 | ≥14岁 | 0.62 | 无 | ①简单快捷 ②可以区分其他进食障碍 | ①信度较低 |
九项回避性/限制性摄食障碍筛查量表(NIAS)[ | 2017 | 自陈量表 | ≥12岁 | 多样本检验为0.79~0.90 | 有 | ①简单快捷 ②信效度较好 | ①需结合其他量表进行区分 ②不适合胃肠道疾病患者筛查 |
回避性/限制性摄食障碍父母报告版问卷(ARFID-Q-PR)[ | 2022 | 他评量表 | 2~10岁儿童 | 0.84 | 无 | ①可以区分其他进食障碍 ②信效度较好 | ①有待在多样本人群推广验证 |
异食癖、回避性/限制性摄食障碍和反刍障碍访谈(PARDI)[ | 2019 | 半结构化访谈 | 全年龄段使用 | 评估ARFID分量表各维度为0.83~0.93 | 无 | ①可用于诊断 ②信效度较好 | ①需要心理医生指导使用 ②大规模筛查人力成本较高 |
[1] |
|
[2] |
|
[3] |
WHO. ICD-11死因和疾病统计(MMS)[EB/OL]. (2023-01)[2023-05-20].
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
American Psychiatric Association. Diagnostic and statistical manual of mental disorders,fifth edition,text revision(DSM-5-TR)[EB/OL]. [2023-05-20].
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[50] |
|
[51] |
|
[52] |
|
[53] |
|
[54] |
|
[55] |
|
[1] | XU Zhijie, QIAN Yi, YAN Ming, LU Yiting, ZHAO Yang. The Influencing Factors and Management Strategies of Multimorbidity Based on Syndemic Theory [J]. Chinese General Practice, 2024, 27(11): 1288-1295. |
[2] | ZHAO Jingjing, ZHANG Zhihong, ZHEN Junping. Research Progress and Prospects of Isocitrate Dehydrogenase Gene Mutation in Chondrosarcoma [J]. Chinese General Practice, 2024, 27(11): 1400-1404. |
[3] | CHEN Wenjin, CHEN Piaoying, YANG Xiaohua, CHEN Yifan, CAI Yefeng, NI Xiaojia. Advance in Epidemiologic Studies of Dietary Patterns Associated with Cerebrovascular Diseases [J]. Chinese General Practice, 2024, 27(08): 900-907. |
[4] | Quality Assessment Group for Quantitative Research,Systematic Review and Guidelines/Consensus of Chinese General Practice. Report on Methodological Quality Assessment of Primary Care and General Practice Research in China in 2021: Quantitative Research, Systematic Review and Guidelines/Consensus Section [J]. Chinese General Practice, 2024, 27(07): 773-783. |
[5] | ZHANG Jinxin, YAO Nengliang, SUN Xiaojie. Qualitative Studies on Care and Support Needs in Elderly People with Physical Disability: a Systematic Review [J]. Chinese General Practice, 2024, 27(07): 867-876. |
[6] | CHEN Qianqian, RUI Fajuan, NI Wenjing, LI Jie. Research Progress in Epidemiology and Risk Factors of Primary Liver Cancer [J]. Chinese General Practice, 2024, 27(06): 637-642. |
[7] | PENG Lei, ZHU Kexiang. Research Progress of Sarcopenic Obesity in Cancer [J]. Chinese General Practice, 2024, 27(06): 643-649. |
[8] | NIU Luyao, YING Xinyu, ZHANG Shuqin, AN Zhixin, JI Jingya, LIU Yuehua, GAO Yuexia. Practice and Reflection on Diabetes Community Management Model from the Perspective of Value Co-creation [J]. Chinese General Practice, 2024, 27(05): 563-569. |
[9] | ZHANG Zhengyan, WANG Zhenzhong, ZHANG Ji, GONG Enying, SHAO Ruitai. Current Status and Implications of Ecology of Medical Care Model in Health Services Research: a Scoping Review [J]. Chinese General Practice, 2024, 27(04): 391-399. |
[10] | ZHANG Xiaoyi, XU Zhihan, YUAN Beibei, WANG Sheng, LIU Xiao, ZHOU Huilan, LI Zhansheng. Patterns and Effects of Collaboration between Primary Care Providers and Medical Specialists in the Delivery of Integrated Health Care Services: a Scoping Review [J]. Chinese General Practice, 2024, 27(04): 400-407. |
[11] | XUE Chao, LI Juan, FANG Qian, YU Jie, HAO Mingqing. Prevalence and Trends for Post-stroke Fatigue in China: a Meta-analysis [J]. Chinese General Practice, 2024, 27(03): 364-374. |
[12] | DENG Yuxuan, HUANG Xuejun, JIANG Yanxia. Recent Advances of Metformin in Treatment of Diabetic Nephropathy [J]. Chinese General Practice, 2024, 27(03): 262-267. |
[13] | LIN Lingjun, GUO Jun, WANG Junwei, GAO Yang, CHEN Huiying, WAN Yongli. A Systematic Review of Risk Prediction Models for Diabetic Foot Development [J]. Chinese General Practice, 2024, 27(03): 357-363. |
[14] | ZHU Chunlin, GAO Jie. Advances in Coronary Microvascular Dysfunction and Metabolic Syndrome [J]. Chinese General Practice, 2024, 27(03): 273-279. |
[15] | ZHENG Jinping, XUE Wujun, JU Chunrong, MA Jun, ZENG Xiaofeng. Identification of COVID-19 Infection in Vulnerable Population and Its Prevention and Treatment Perspectives [J]. Chinese General Practice, 2024, 27(02): 132-137. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||